Want to join the conversation?
$JWN 2Q15 Call: We maintained a strong financial position, ending the quarter with a cash balance of $425MM and adjusted debt-to-EBITDA of 2.1x. Maintaining a balanced capital allocation here today, we incurred $425MM in net CapEx, paid $140MM in dividends and $265MM in share repurchases with $735MM remaining under current repurchase authorization
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?